Imaging biomarkers in DME and RVO: from disease development to treatment

This advanced course explores the role of imaging biomarkers in the diagnosis, monitoring, and treatment of diabetic macular oedema and retinal vein occlusion. Through high-resolution OCT, OCT-angiography, multimodal imaging, and artificial intelligence applications, participants will gain a deeper understanding of disease mechanisms and learn how to translate imaging findings into personalized, evidence-based therapeutic decisions.

ESASO Scientific Director: Mario Romano
Course Scientific Coordinator: Giuseppe Querques and Riccardo Sacconi

An application has been made to the EACCMEยฎ for CME accreditation of this event

Teaching language: English ๐Ÿ‡ฌ๐Ÿ‡ง

Next Course in 2027 ๐ŸŽฏ

Only 20 seats available ๐Ÿ”ฅ

โญโญโญโญโญ More than 1700 students

๐ŸŽ—๏ธ This course awards you with 1/5 MDHO Points

What you'll learn

โœ”๏ธ

How to identify clinically relevant OCT and OCT-A biomarkers in DME and RVO

โœ”๏ธ

How retinal ischemia and structural changes influence disease progression

โœ”๏ธ

How multimodal imaging improves diagnostic accuracy and treatment planning

โœ”๏ธ

How imaging biomarkers guide therapeutic choices, including treatment switching

Skills you'll acquire

Advanced OCT and OCT-A interpretation

Imaging-based clinical decision-making

Biomarker-driven treatment selection

Multimodal retinal imaging analysis

Early identification of disease progression

From

Free

Take me to the registration form

Date: 13 May 2026
Venue: Online on eLOS
Level: Advanced

This course includes:

๐Ÿง‘๐Ÿปโ€๐Ÿซ2 educational hours
๐Ÿง‘๐Ÿปโ€๐Ÿซ International, experienced Faculty
โฌ‡๏ธ Downloadable resources
๐Ÿ—จ๏ธ eLOS account
๐Ÿฆธ๐Ÿปโ€โ™‚๏ธ Assistance of Event Manager
๐Ÿ… Accreditation Certificate
๐Ÿ“œ ESASO Certificate of Attendance
๐Ÿ‡จ๐Ÿ‡ญ Swiss-level organisation

Course sponsorIndependent support grant

Course Programme